These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2661381)

  • 1. [Pathogenesis and therapy of dilated cardiomyopathy. Possible indications for calcium antagonists].
    Figulla HR
    Fortschr Med; 1989 May; 107(16):370. PubMed ID: 2661381
    [No Abstract]   [Full Text] [Related]  

  • 2. Arguments supporting the use of calcium antagonists in idiopathic dilated cardiomyopathy: theoretical considerations and clinical results.
    Figulla HR; Kreuzer H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S45-9. PubMed ID: 1707115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists in cardiomyopathy].
    Takabatake Y
    Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
    van der Harst P; Voors AA; van Veldhuisen DJ
    Circulation; 2004 Feb; 109(5):e34; author reply e34. PubMed ID: 14769695
    [No Abstract]   [Full Text] [Related]  

  • 5. [A preliminary observation on the therapeutic effect of the calcium antagonist herbesser on primary congestive cardiomyopathy: a clinical survey of 15 cases].
    Huang DX; Ding ZC
    Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):587-90, 636. PubMed ID: 3568838
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium antagonists in congestive heart failure].
    Barbieri L; Mestroni L; Camerini F
    G Ital Cardiol; 1988 Nov; 18(11):989-96. PubMed ID: 3073994
    [No Abstract]   [Full Text] [Related]  

  • 7. [Direct myocardial anti-ischemic effect of diltiazem in the human].
    Kober G; Kästner R; Hopf R; Kaltenbach M
    Z Kardiol; 1986 Jul; 75(7):386-93. PubMed ID: 2945332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New pathogenetic mechanisms of idiopathic dilated cardiomyopathy: changes in coronary microcirculation].
    Neglia D
    Recenti Prog Med; 2003 Jun; 94(6):247-52. PubMed ID: 12793095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the long-term atenolol therapy on the structural and functional parameters of the left ventricle in patients with dilated cardiomyopathy].
    Sisakian AS
    Eksp Klin Farmakol; 1997; 60(6):17-20. PubMed ID: 9460590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-receptor blockers in dilated cardiomyopathy].
    Osterziel KJ
    Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
    [No Abstract]   [Full Text] [Related]  

  • 11. Dilated cardiomyopathy. I: Vasodilator therapy.
    Vine DL
    Kans Med; 1989 Feb; 90(2):55, 53. PubMed ID: 2645458
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism(s) of calcium antagonists and ischemia.
    Hugenholtz PG; de Jong JW
    Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study on the therapeutic effects of a calcium antagonist (diltiazem) on primary congestive cardiomyopathy. A clinical survey of 15 cases.
    Huang DX; Ding ZC; Chen KL; Li HE
    Jpn Heart J; 1988 May; 29(3):325-33. PubMed ID: 3172476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-blockade therapy in heart failure. Rational bases of the interpretation of clinical data and clinical evidence in search of rational interpretation].
    Branzi A; Rapezzi C
    G Ital Cardiol; 1988 Oct; 18(10):843-6. PubMed ID: 2907744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of dilated cardiomyopathy].
    Guazzi MD; Alimento M; Mundo E; Viecca M
    Cardiologia; 1985 Oct; 30(10):909-12. PubMed ID: 2878720
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary flow reserve in dilated cardiomyopathy: an important pathophysiological tool to be considered among, but not instead of, other well-established prognostic factors.
    de Gregorio C
    Eur Heart J; 2006 Nov; 27(21):2609; author reply 2609-10. PubMed ID: 17030520
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary blood flow in patients with idiopathic dilated cardiomyopathy.
    Iskandrian AE
    Cathet Cardiovasc Diagn; 1997 Jun; 41(2):164-5. PubMed ID: 9184289
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of diltiazem in the treatment of acute myocardial infarct].
    Milazzotto F; Citone C; Tubaro M
    Cardiologia; 1985 Feb; 30 Suppl 2():37-42. PubMed ID: 3830396
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcium antagonists. Properties and current indications].
    Amoroso A; Lanciotti G; Mammarella A
    Recenti Prog Med; 1984 Apr; 75(4):353-60. PubMed ID: 6374795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute hemodynamic effect of verapamil, used intravenously, in patients with primary dilated cardiomyopathy].
    Manfroi WC; Ludwig RT; Vieira SR; Goldim JR; Das SK; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1985 Nov; 45(5):371-5. PubMed ID: 3915860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.